Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo.
about
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunityIL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expressionIL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivoChallenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.Memories that last forever: strategies for optimizing vaccine T-cell memory.MEKK3 is essential for lymphopenia-induced T cell proliferation and survival.IL-2 complex treatment can protect naive mice from bacterial and viral infection.Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenanceThe T-cell response to HIV.Induction and function of virus-specific CD4+ T cell responses.MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Rα complex.CD8+ T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2.Eos Is Redundant for Regulatory T Cell Function but Plays an Important Role in IL-2 and Th17 Production by CD4+ Conventional T CellsAn Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis.Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR.Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection.Early Subretinal Allograft Rejection Is Characterized by Innate Immune Activity.Transient enhanced IL-2R signaling early during priming rapidly amplifies development of functional CD8+ T effector-memory cells.Interleukin 2: from immunostimulation to immunoregulation and back again.Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia.Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes.Exploring regulatory mechanisms of CD8+ T cell contraction.Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapyMHC-dependent desensitization of intrinsic anti-self reactivity.Negative regulators in homeostasis of naïve peripheral T cells.Self/non-self discrimination and the problem of keeping T cells alive.Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansionT cell homeostasis.Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.Endoplasmic reticulum stress regulator XBP-1 contributes to effector CD8+ T cell differentiation during acute infection.Functions of γC cytokines in immune homeostasis: current and potential clinical applications.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Regulation of antiviral CD8 T-cell responsesMathematical Models of the Impact of IL2 Modulation Therapies on T Cell DynamicsVaccination issues in patients with chronic kidney disease.
P2860
Q24317691-FC846C79-8AE6-4F59-8F59-11C666DFB267Q28073154-8A9B279E-933C-4016-B752-4A05EA74F41AQ28730751-22475ABF-1A75-4C7D-902D-9A7E6F48E163Q33719745-AC408FF7-5EF0-49AB-A550-069D8816CEC4Q33775493-119F341D-EC41-491A-B953-1A209D37F463Q33811204-956EBB2C-D507-4D29-A9E1-953F12F613A4Q34060493-BB437496-117D-4656-A830-F5A09DB25350Q34072509-EFAC23D2-45AC-470F-A93A-796D8A334224Q34470815-CEB5D691-A1E2-4603-8F62-B19CF93FA8B1Q34472025-6E8F67E6-A7C4-4CB2-9778-16B8B5FC437CQ34642996-63322BC4-EECC-4849-A954-DEF9397D0841Q34856857-94929D00-814F-481F-BDCF-3A5986C68F49Q35147335-320EBF01-EC04-4B30-BCB3-6C03865F8FB4Q35623191-2DDDA5DE-EBB3-4EC4-8899-BB8D98BD8F75Q35816008-9BE562D8-2D89-49AF-8D01-3BE50C4EFF44Q35931508-27243F89-F126-4FCD-B220-D3510F2058E4Q35962978-24FD8ACD-EDA6-47EC-B877-AC0963D6119EQ36018593-7C078138-A53D-477F-B75E-2178BBA12E93Q36109361-306789B4-4EC0-47C5-B9C4-905BE2104CBBQ36255088-61C76648-3314-46A3-9F9C-AAD2FE3DB488Q36339358-BB81A390-E9FB-41D6-9687-9D88D02B2E61Q36495075-2D144CCD-8CF2-4FEA-A7B9-A9BCD1B6B28DQ36694460-6B9A1FFC-A0FE-41D7-90E9-329EC63224A1Q36741326-5A086D5F-FAA6-46C1-9969-BF83FFBEA1B8Q36946510-80A30C0F-A817-4F5B-80F6-367FCF2A9A16Q36954938-094E34A1-FE7E-4FE5-A1A4-F7B3A43FF080Q36978119-BEE7FA3E-F7CE-4301-84B7-C555E195ECC9Q36983409-A53571C3-6900-4FD6-B994-EBBAC66DC30EQ37028785-EE395A6A-900A-4380-98E4-084224D36370Q37095794-FE544FDA-C32A-4C98-B30C-7B00DE614F10Q37106778-77FA985F-8669-466A-AB09-D1470CD906A8Q37117568-29291CB5-14E4-4020-9B63-BBB724FA9E05Q37163535-64A4A272-69F5-4AA4-95AA-9833BE0A821AQ37251467-C10587CC-649B-4CB2-8EF6-F5C34CF429E6Q37418550-C00A4C3B-809F-44AA-A39F-EC88EF30463EQ37475949-4D63FB18-BDCF-4E62-BADA-EE10A984B739Q37952804-1D47C66A-4720-4060-A586-D6CB4812887FQ38165191-3570E1D5-CEDD-4BC7-9137-31969F37E633Q38174602-18F959A5-4483-4BBA-BE7A-62107D927AEBQ38176987-D317347B-F952-41E4-8615-8895C3B41E72
P2860
Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@ast
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@en
type
label
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@ast
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@en
prefLabel
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@ast
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@en
P2860
P356
P1476
Naive CD8+ T cells differentia ...... L-2 complex treatment in vivo.
@en
P2093
Daisuke Kamimura
Michael J Bevan
P2860
P304
P356
10.1084/JEM.20070543
P407
P577
2007-07-30T00:00:00Z